Literature DB >> 1918029

Novel proliferative effect of phospholipase A2 in Swiss 3T3 cells via specific binding site.

H Arita1, K Hanasaki, T Nakano, S Oka, H Teraoka, K Matsumoto.   

Abstract

Phospholipase A2 (PLA2), EC 3.1.1.4, which catalyzes the release of free fatty acids from the sn-2 position of glycerophospholipids, has been extensively studied from the viewpoint of eicosanoid production (Arita, H., Nakano, T., and Hanasaki, K. (1989) Prog. Lipid Res. 28, 273-301). Several lines of evidence suggest that extracellular PLA2 is pathophysiologically related to some disorders, including inflammation and hypersensitivity. Despite this, little is known of the precise mechanism of the pathological processes as well as their intrinsic correlation with dysfunction. Here, we report a novel PLA2 action on the proliferation of Swiss 3T3 fibroblasts via specific binding sites of approximately Mr 200,000. Pancreatic type PLA2 in the active form specifically recognized the sites and stimulated thymidine incorporation in DNA. Its inactive zymogen and other PLA2s from platelets, snake, and bee venoms showed much lesser activities. Although the physiological significance remains to be identified, our finding is the first to offer a new viewpoint on the effect of mammalian extracellular PLA2 on cellular function.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1918029

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Binding and internalization of extracellular type-I phospholipase A2 in uterine stromal cells.

Authors:  G P Rossini; J M Fayard; C Tessier; C Laugier
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

Review 2.  The regulation of AMPA receptor-binding sites.

Authors:  K K Dev; J M Henley
Journal:  Mol Neurobiol       Date:  1998       Impact factor: 5.590

3.  Proliferative effect of ammodytin L from the venom of Vipera ammodytes on 208F rat fibroblasts in culture.

Authors:  S Rufini; M P Cesaroni; N Balestro; P Luly
Journal:  Biochem J       Date:  1996-12-01       Impact factor: 3.857

Review 4.  The role of secretory phospholipase A₂ in the central nervous system and neurological diseases.

Authors:  Tatsurou Yagami; Yasuhiro Yamamoto; Hiromi Koma
Journal:  Mol Neurobiol       Date:  2013-10-10       Impact factor: 5.590

5.  Asp-49 is not an absolute prerequisite for the enzymic activity of low-M(r) phospholipases A2: purification, characterization and computer modelling of an enzymically active Ser-49 phospholipase A2, ecarpholin S, from the venom of Echis carinatus sochureki (saw-scaled viper).

Authors:  J Polgár; E M Magnenat; M C Peitsch; T N Wells; K J Clemetson
Journal:  Biochem J       Date:  1996-11-01       Impact factor: 3.857

6.  Secreted Phospholipase A2 Group X Acts as an Adjuvant for Type 2 Inflammation, Leading to an Allergen-Specific Immune Response in the Lung.

Authors:  Herbert Luke Ogden; Ying Lai; James D Nolin; Dowon An; Charles W Frevert; Michael H Gelb; William A Altemeier; Teal S Hallstrand
Journal:  J Immunol       Date:  2020-04-27       Impact factor: 5.422

7.  The localization of phospholipase A2 in the secretory granule.

Authors:  S P Chock; E A Schmauder-Chock; E Cordella-Miele; L Miele; A B Mukherjee
Journal:  Biochem J       Date:  1994-06-15       Impact factor: 3.857

Review 8.  Role of secretory phospholipase a(2) in CNS inflammation: implications in traumatic spinal cord injury.

Authors:  W Lee Titsworth; Nai-Kui Liu; Xiao-Ming Xu
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-06       Impact factor: 4.388

9.  A direct role for secretory phospholipase A2 and lysophosphatidylcholine in the mediation of LPS-induced gastric injury.

Authors:  Elizabeth J Dial; Duy M Tran; Jimmy J Romero; Mayssa Zayat; Lenard M Lichtenberger
Journal:  Shock       Date:  2010-06       Impact factor: 3.454

10.  Effects of human parvovirus B19 VP1 unique region protein on macrophage responses.

Authors:  Bor-Show Tzang; Chun-Ching Chiu; Chun-Chou Tsai; Yi-Ju Lee; I-Jung Lu; Jing-Yu Shi; Tsai-Ching Hsu
Journal:  J Biomed Sci       Date:  2009-01-24       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.